{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:24:14Z","timestamp":1793726654779,"version":"4.6.1"},"reference-count":74,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"8","license":[{"start":{"date-parts":[[2018,7,5]],"date-time":"2018-07-05T00:00:00Z","timestamp":1530748800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest. Ophthalmol. Vis. Sci."],"published-print":{"date-parts":[[2018,7,5]]},"DOI":"10.1167\/iovs.18-23831","type":"journal-article","created":{"date-parts":[[2018,7,20]],"date-time":"2018-07-20T18:20:36Z","timestamp":1532110836000},"page":"3294","source":"Crossref","is-referenced-by-count":25,"title":["SWATH-MS Proteomic Analysis of Oxygen-Induced Retinopathy Reveals Novel Potential Therapeutic Targets"],"prefix":"10.1167","volume":"59","author":[{"given":"Maria","family":"V\u00e4h\u00e4tupa","sequence":"first","affiliation":[{"name":"Faculty of Medicine & Life Sciences, University of Tampere, Tampere, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janika","family":"N\u00e4ttinen","sequence":"additional","affiliation":[{"name":"Faculty of Medicine & Life Sciences, University of Tampere, Tampere, Finland"},{"name":"The Center for Proteomics and Personalized Medicine, Tampere, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antti","family":"Jylh\u00e4","sequence":"additional","affiliation":[{"name":"Faculty of Medicine & Life Sciences, University of Tampere, Tampere, Finland"},{"name":"The Center for Proteomics and Personalized Medicine, Tampere, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulla","family":"Aapola","sequence":"additional","affiliation":[{"name":"Faculty of Medicine & Life Sciences, University of Tampere, Tampere, Finland"},{"name":"The Center for Proteomics and Personalized Medicine, Tampere, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marko","family":"Kataja","sequence":"additional","affiliation":[{"name":"Eye Centre, Tampere University Hospital, Tampere, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peeter","family":"K\u00f6\u00f6bi","sequence":"additional","affiliation":[{"name":"Faculty of Medicine & Life Sciences, University of Tampere, Tampere, Finland"},{"name":"Eye Centre, Tampere University Hospital, Tampere, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tero A. H.","family":"J\u00e4rvinen","sequence":"additional","affiliation":[{"name":"Faculty of Medicine & Life Sciences, University of Tampere, Tampere, Finland"},{"name":"Department of Musculoskeletal Disorders, Tampere University Hospital, Tampere, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannu","family":"Uusitalo","sequence":"additional","affiliation":[{"name":"Faculty of Medicine & Life Sciences, University of Tampere, Tampere, Finland"},{"name":"The Center for Proteomics and Personalized Medicine, Tampere, Finland"},{"name":"Eye Centre, Tampere University Hospital, Tampere, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannele","family":"Uusitalo-J\u00e4rvinen","sequence":"additional","affiliation":[{"name":"Faculty of Medicine & Life Sciences, University of Tampere, Tampere, Finland"},{"name":"Eye Centre, Tampere University Hospital, Tampere, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"key":"i1552-5783-59-8-3294-b01","doi-asserted-by":"crossref","unstructured":"Reynolds JD. Insights in ROP. Am Orthopt J. 2014; 64: 43\u201353.","DOI":"10.3368\/aoj.64.1.43"},{"key":"i1552-5783-59-8-3294-b02","doi-asserted-by":"crossref","unstructured":"Fong DS, Aiello LP, Ferris FL III, Klein R. Diabetic retinopathy. Diabetes Care. 2004; 27: 2540\u20132553.","DOI":"10.2337\/diacare.27.10.2540"},{"key":"i1552-5783-59-8-3294-b03","doi-asserted-by":"crossref","unstructured":"Laouri M, Chen E, Looman M, Gallagher M. The burden of disease of retinal vein occlusion: review of the literature. Eye (Lond). 2011; 25: 981\u2013988.","DOI":"10.1038\/eye.2011.92"},{"key":"i1552-5783-59-8-3294-b04","doi-asserted-by":"crossref","unstructured":"Laatikainen L, Ojamo M, Rudanko SL, et al. Improving visual prognosis of the diabetic patients during the past 30 years based on the data of the Finnish Register of Visual Impairment. Acta Ophthalmol. 2016; 94: 226\u2013231.","DOI":"10.1111\/aos.12952"},{"key":"i1552-5783-59-8-3294-b05","unstructured":"Gissler M, Ojamo M, Ritvanen A, Uusitalo H. Pediatric ocular disorders and visual handicap in Finland\u2014what do the registers tell? Duodecim. 2017; 133: 159\u2013166."},{"key":"i1552-5783-59-8-3294-b06","unstructured":"Smith LE, Wesolowski E, McLellan A, et al. Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci. 1994; 35: 101\u2013111."},{"key":"i1552-5783-59-8-3294-b07","doi-asserted-by":"crossref","unstructured":"Stahl A, Connor KM, Sapieha P, et al. The mouse retina as an angiogenesis model. Invest Ophthalmol Vis Sci. 2010; 51: 2813\u20132826.","DOI":"10.1167\/iovs.10-5176"},{"key":"i1552-5783-59-8-3294-b08","doi-asserted-by":"crossref","unstructured":"Vessey KA, Wilkinson-Berka JL, Fletcher EL. Characterization of retinal function and glial cell response in a mouse model of oxygen-induced retinopathy. J Comp Neurol. 2011; 519: 506\u2013527.","DOI":"10.1002\/cne.22530"},{"key":"i1552-5783-59-8-3294-b09","doi-asserted-by":"crossref","unstructured":"Cifani P, Kentsis A. Toward comprehensive and quantitative proteomics for diagnosis and therapy of human disease. Proteomics. 2017; 17: 1600079.","DOI":"10.1002\/pmic.201600079"},{"key":"i1552-5783-59-8-3294-b10","doi-asserted-by":"crossref","unstructured":"Kim SJ, Jin J, Kim YJ, Kim Y, Yu HG. Retinal proteome analysis in a mouse model of oxygen-induced retinopathy. J Proteome Res. 2012; 11: 5186\u20135203.","DOI":"10.1021\/pr300389r"},{"key":"i1552-5783-59-8-3294-b11","unstructured":"Zhou L, Xinling L, Koh SK, Xiaorong L, Beuerman RW. Quantitative proteomic analysis of retina in oxygen-induced retinopathy mice using iTRAQ with 2D NanoLC-nanoESI-MS\/MS. Jiomics. 2011; 1: 226\u2013235."},{"key":"i1552-5783-59-8-3294-b12","doi-asserted-by":"crossref","unstructured":"Tu C, Beharry KD, Shen X, et al. Proteomic profiling of the retinas in a neonatal rat model of oxygen-induced retinopathy with a reproducible ion-current-based MS1 approach. J Proteome Res. 2015; 14: 2109\u20132120.","DOI":"10.1021\/pr501238m"},{"key":"i1552-5783-59-8-3294-b13","doi-asserted-by":"crossref","unstructured":"Gillet LC, Navarro P, Tate S, et al. Targeted data extraction of the MS\/MS spectra generated by data-independent acquisition: a new concept for consistent and accurate proteome analysis. Mol Cell Proteomics. 2012; 11: O111.016717.","DOI":"10.1074\/mcp.O111.016717"},{"key":"i1552-5783-59-8-3294-b14","doi-asserted-by":"crossref","unstructured":"Rosenberger G, Koh CC, Guo T, et al. A repository of assays to quantify 10,000 human proteins by SWATH-MS. Sci Data. 2014; 1: 140031.","DOI":"10.1038\/sdata.2014.31"},{"key":"i1552-5783-59-8-3294-b15","doi-asserted-by":"crossref","unstructured":"Uusitalo-J\u00e4rvinen H, Kurokawa T, Mueller BM, Andrade-Gordon P, Friedlander M, Ruf W. Role of protease activated receptor 1 and 2 signaling in hypoxia-induced angiogenesis. Arterioscler Thromb Vasc Biol. 2007; 27: 1456\u20131462.","DOI":"10.1161\/ATVBAHA.107.142539"},{"key":"i1552-5783-59-8-3294-b16","doi-asserted-by":"crossref","unstructured":"V\u00e4h\u00e4tupa M, Prince S, Vataja S, et al. Lack of R-Ras leads to increased vascular permeability in ischemic retinopathy. Invest Ophthalmol Vis Sci. 2016; 57: 4898\u20134909.","DOI":"10.1167\/iovs.16-19212"},{"key":"i1552-5783-59-8-3294-b17","doi-asserted-by":"crossref","unstructured":"V\u00e4h\u00e4tupa M, Cordova ZM, Aittom\u00e4ki S, et al. Furin deficiency in myeloid cells leads to attenuated revascularization in a mouse-model of oxygen-induced retinopathy. Exp Eye Res. 2018; 166: 160\u2013167.","DOI":"10.1016\/j.exer.2017.10.013"},{"key":"i1552-5783-59-8-3294-b18","doi-asserted-by":"crossref","unstructured":"Huang FJ, You WK, Bonaldo P, Seyfried TN, Pasquale EB, Stallcup WB. Pericyte deficiencies lead to aberrant tumor vascularization in the brain of the NG2 null mouse. Dev Biol. 2010; 344: 1035\u20131046.","DOI":"10.1016\/j.ydbio.2010.06.023"},{"key":"i1552-5783-59-8-3294-b19","doi-asserted-by":"crossref","unstructured":"Cho S, Irianto J, Discher DE. Mechanosensing by the nucleus: from pathways to scaling relationships. J Cell Biol. 2017; 216: 305\u2013315.","DOI":"10.1083\/jcb.201610042"},{"key":"i1552-5783-59-8-3294-b20","doi-asserted-by":"crossref","unstructured":"Discher DE, Smith L, Cho S, Colasurdo M, Garcia AJ, Safran S. Matrix mechanosensing: from scaling concepts in 'omics data to mechanisms in the nucleus, regeneration, and cancer. Annu Rev Biophys. 2017; 46: 295\u2013315.","DOI":"10.1146\/annurev-biophys-062215-011206"},{"key":"i1552-5783-59-8-3294-b21","doi-asserted-by":"crossref","unstructured":"Irianto J, Pfeifer CR, Xia Y, Discher DE. SnapShot: mechanosensing matrix. Cell. 2016; 165: 1820\u20131820.e1.","DOI":"10.1016\/j.cell.2016.06.002"},{"key":"i1552-5783-59-8-3294-b22","doi-asserted-by":"crossref","unstructured":"Bordeleau F, Mason BN, Lollis EM, et al. Matrix stiffening promotes a tumor vasculature phenotype. Proc Natl Acad Sci U S A. 2017; 114: 492\u2013497.","DOI":"10.1073\/pnas.1613855114"},{"key":"i1552-5783-59-8-3294-b23","doi-asserted-by":"crossref","unstructured":"Barber AJ. A new view of diabetic retinopathy: a neurodegenerative disease of the eye. Prog Neuropsychopharmacol Biol Psychiatry. 2003; 27: 283\u2013290.","DOI":"10.1016\/S0278-5846(03)00023-X"},{"key":"i1552-5783-59-8-3294-b24","doi-asserted-by":"crossref","unstructured":"Kern TS. Interrelationships between the retinal neuroglia and vasculature in diabetes. Diabetes Metab J. 2014; 38: 163\u2013170.","DOI":"10.4093\/dmj.2014.38.3.163"},{"key":"i1552-5783-59-8-3294-b25","doi-asserted-by":"crossref","unstructured":"Nakahara T, Mori A, Kurauchi Y, Sakamoto K, Ishii K. Neurovascular interactions in the retina: physiological and pathological roles. J Pharmacol Sci. 2013; 123: 79\u201384.","DOI":"10.1254\/jphs.13R03CP"},{"key":"i1552-5783-59-8-3294-b26","doi-asserted-by":"crossref","unstructured":"Diokmetzidou A, Soumaka E, Kloukina I, et al. Desmin and aB-crystallin interplay in the maintenance of mitochondrial homeostasis and cardiomyocyte survival. J Cell Sci. 2016; 129: 3705\u20133720.","DOI":"10.1242\/jcs.192203"},{"key":"i1552-5783-59-8-3294-b27","doi-asserted-by":"crossref","unstructured":"Ishikawa K, Sreekumar PG, Spee C, et al. aB-Crystallin regulates subretinal fibrosis by modulation of epithelial-mesenchymal transition. Am J Pathol. 2016; 186: 859\u2013873.","DOI":"10.1016\/j.ajpath.2015.11.014"},{"key":"i1552-5783-59-8-3294-b28","doi-asserted-by":"crossref","unstructured":"Kannan R, Sreekumar PG, Hinton DR. Alpha crystallins in the retinal pigment epithelium and implications for the pathogenesis and treatment of age-related macular degeneration. Biochim Biophys Acta. 2016; 1860: 258\u2013268.","DOI":"10.1016\/j.bbagen.2015.05.016"},{"key":"i1552-5783-59-8-3294-b29","doi-asserted-by":"crossref","unstructured":"Sinha D, Klise A, Sergeev Y, et al. \u00dfA3\/A1-crystallin in astroglial cells regulates retinal vascular remodeling during development. Mol Cell Neurosci. 2008; 37: 85\u201395.","DOI":"10.1016\/j.mcn.2007.08.016"},{"key":"i1552-5783-59-8-3294-b30","doi-asserted-by":"crossref","unstructured":"Zhang C, Gehlbach P, Gongora C, et al. A potential role for \u00df- and ?-crystallins in the vascular remodeling of the eye. Dev Dyn. 2005; 234: 36\u201347.","DOI":"10.1002\/dvdy.20494"},{"key":"i1552-5783-59-8-3294-b31","doi-asserted-by":"crossref","unstructured":"Kase S, He S, Sonoda S, et al. aB-crystallin regulation of angiogenesis by modulation of VEGF. Blood. 2010; 115: 3398\u20133406.","DOI":"10.1182\/blood-2009-01-197095"},{"key":"i1552-5783-59-8-3294-b32","doi-asserted-by":"crossref","unstructured":"Kannan R, Sreekumar PG, Hinton DR. Novel roles for a-crystallins in retinal function and disease. Prog Retin Eye Res. 2012; 31: 576\u2013604.","DOI":"10.1016\/j.preteyeres.2012.06.001"},{"key":"i1552-5783-59-8-3294-b33","doi-asserted-by":"crossref","unstructured":"Vazquez-Chona F, Song BK, Geisert EE Jr. Temporal changes in gene expression after injury in the rat retina. Invest Ophthalmol Vis Sci. 2004; 45: 2737\u20132746.","DOI":"10.1167\/iovs.03-1047"},{"key":"i1552-5783-59-8-3294-b34","doi-asserted-by":"crossref","unstructured":"Smolich BD, Tarkington SK, Saha MS, Grainger RM. Xenopus ?-crystallin gene expression: evidence that the ?-crystallin gene family is transcribed in lens and nonlens tissues. Mol Cell Biol. 1994; 14: 1355\u20131363.","DOI":"10.1128\/MCB.14.2.1355"},{"key":"i1552-5783-59-8-3294-b35","doi-asserted-by":"crossref","unstructured":"Ruebsam A, Dulle JE, Myers AM, et al. A specific phosphorylation regulates the protective role of aA-crystallin in diabetes. JCI Insight. 2018; 3: e97919.","DOI":"10.1172\/jci.insight.97919"},{"key":"i1552-5783-59-8-3294-b36","doi-asserted-by":"crossref","unstructured":"Nagaraj RH, Nahomi RB, Mueller NH, Raghavan CT, Ammar DA, Petrash JM. Therapeutic potential of a-crystallin. Biochim Biophys Acta. 2016; 1860: 252\u2013257.","DOI":"10.1016\/j.bbagen.2015.03.012"},{"key":"i1552-5783-59-8-3294-b37","doi-asserted-by":"crossref","unstructured":"Cringle SJ, Yu DY, Alder VA. Intraretinal oxygen tension in the rat eye. Graefes Arch Clin Exp Ophthalmol. 1991; 229: 574\u2013577.","DOI":"10.1007\/BF00203324"},{"key":"i1552-5783-59-8-3294-b38","doi-asserted-by":"crossref","unstructured":"Huang B, Deora AB, He KL, et al. Hypoxia-inducible factor-1 drives annexin A2 system-mediated perivascular fibrin clearance in oxygen-induced retinopathy in mice. Blood. 2011; 118: 2918\u20132929.","DOI":"10.1182\/blood-2011-03-341214"},{"key":"i1552-5783-59-8-3294-b39","doi-asserted-by":"crossref","unstructured":"Delanghe JR, Speeckaert R, Speeckaert MM. Behind the scenes of vitamin D binding protein: more than vitamin D binding. Best Pract Res Clin Endocrinol Metab. 2015; 29: 773\u2013786.","DOI":"10.1016\/j.beem.2015.06.006"},{"key":"i1552-5783-59-8-3294-b40","doi-asserted-by":"crossref","unstructured":"Albert DM, Scheef EA, Wang S, et al. Calcitriol is a potent inhibitor of retinal neovascularization. Invest Ophthalmol Vis Sci. 2007; 48: 2327\u20132334.","DOI":"10.1167\/iovs.06-1210"},{"key":"i1552-5783-59-8-3294-b41","doi-asserted-by":"crossref","unstructured":"Merrigan SL, Kennedy BN. Vitamin D receptor agonists regulate ocular developmental angiogenesis and modulate expression of dre-miR-21 and VEGF. Br J Pharmacol. 2017; 174: 2636\u20132651.","DOI":"10.1111\/bph.13875"},{"key":"i1552-5783-59-8-3294-b42","doi-asserted-by":"crossref","unstructured":"Segura I, Lange C, Knevels E, et al. The oxygen sensor PHD2 controls dendritic spines and synapses via modification of filamin A. Cell Rep. 2016; 14: 2653\u20132667.","DOI":"10.1016\/j.celrep.2016.02.047"},{"key":"i1552-5783-59-8-3294-b43","doi-asserted-by":"crossref","unstructured":"Zheng X, Zhou AX, Rouhi P, et al. Hypoxia-induced and calpain-dependent cleavage of filamin A regulates the hypoxic response. Proc Natl Acad Sci U S A. 2014; 111: 2560\u20132565.","DOI":"10.1073\/pnas.1320815111"},{"key":"i1552-5783-59-8-3294-b44","unstructured":"Salimi R, Bandaru S, Devarakonda S, et al. Blocking the cleavage of filamin A by calpain inhibitor decreases tumor cell growth. Anticancer Res. 2018; 38: 2079\u20132085."},{"key":"i1552-5783-59-8-3294-b45","doi-asserted-by":"crossref","unstructured":"Griffiths GS, Grundl M, Allen JS III, Matter ML. R-Ras interacts with filamin A to maintain endothelial barrier function. J Cell Physiol. 2011; 226: 2287\u20132296.","DOI":"10.1002\/jcp.22565"},{"key":"i1552-5783-59-8-3294-b46","doi-asserted-by":"crossref","unstructured":"Sawada J, Urakami T, Li F, et al. Small GTPase R-Ras regulates integrity and functionality of tumor blood vessels. Cancer Cell. 2012; 22: 235\u2013249.","DOI":"10.1016\/j.ccr.2012.06.013"},{"key":"i1552-5783-59-8-3294-b47","doi-asserted-by":"crossref","unstructured":"Sawada J, Komatsu M. Normalization of tumor vasculature by R-Ras. Cell Cycle. 2012; 11: 4285\u20134286.","DOI":"10.4161\/cc.22465"},{"key":"i1552-5783-59-8-3294-b48","doi-asserted-by":"crossref","unstructured":"Ichimiya H, Maeda K, Enomoto A, Weng L, Takahashi M, Murohara T. Girdin\/GIV regulates transendothelial permeability by controlling VE-cadherin trafficking through the small GTPase, R-Ras. Biochem Biophys Res Commun. 2015; 461: 260\u2013267.","DOI":"10.1016\/j.bbrc.2015.04.012"},{"key":"i1552-5783-59-8-3294-b49","doi-asserted-by":"crossref","unstructured":"Komatsu M, Ruoslahti E. R-Ras is a global regulator of vascular regeneration that suppresses intimal hyperplasia and tumor angiogenesis. Nat Med. 2005; 11: 1346\u20131350.","DOI":"10.1038\/nm1324"},{"key":"i1552-5783-59-8-3294-b50","doi-asserted-by":"crossref","unstructured":"Zhao K, Li X, Lin B, et al. Oroxyloside inhibits angiogenesis through suppressing internalization of VEGFR2\/Flk-1 in endothelial cells. J Cell Physiol. 2018; 233: 3454\u20133464.","DOI":"10.1002\/jcp.26198"},{"key":"i1552-5783-59-8-3294-b51","doi-asserted-by":"crossref","unstructured":"Li F, Sawada J, Komatsu M. R-Ras-Akt axis induces endothelial lumenogenesis and regulates the patency of regenerating vasculature. Nat Commun. 2017; 8: 1720.","DOI":"10.1038\/s41467-017-01865-x"},{"key":"i1552-5783-59-8-3294-b52","doi-asserted-by":"crossref","unstructured":"Pecci A, Ma X, Savoia A, Adelstein RS. MYH9: structure, functions and role of non-muscle myosin IIA in human disease. Gene. 2018; 664: 152\u2013167.","DOI":"10.1016\/j.gene.2018.04.048"},{"key":"i1552-5783-59-8-3294-b53","doi-asserted-by":"crossref","unstructured":"Huynh J, Nishimura N, Rana K, et al. Age-related intimal stiffening enhances endothelial permeability and leukocyte transmigration. Sci Transl Med. 2011; 3: 112\u2013122.","DOI":"10.1126\/scitranslmed.3002761"},{"key":"i1552-5783-59-8-3294-b54","doi-asserted-by":"crossref","unstructured":"Lampi MC, Reinhart-King CA. Targeting extracellular matrix stiffness to attenuate disease: from molecular mechanisms to clinical trials. Sci Transl Med. 2018; 10: eaao0475.","DOI":"10.1126\/scitranslmed.aao0475"},{"key":"i1552-5783-59-8-3294-b55","doi-asserted-by":"crossref","unstructured":"Kohn JC, Lampi MC, Reinhart-King CA. Age-related vascular stiffening: causes and consequences. Front Genet. 2015; 6: 112.","DOI":"10.3389\/fgene.2015.00112"},{"key":"i1552-5783-59-8-3294-b56","doi-asserted-by":"crossref","unstructured":"Morrison AR, Yarovinsky TO, Young BD, et al. Chemokine-coupled \u00df2 integrin-induced macrophage Rac2-Myosin IIA interaction regulates VEGF-A mRNA stability and arteriogenesis. J Exp Med. 2014; 211: 1957\u20131968.","DOI":"10.1084\/jem.20132130"},{"key":"i1552-5783-59-8-3294-b57","doi-asserted-by":"crossref","unstructured":"Huang Y, Shi H, Zhou H, Song X, Yuan S, Luo Y. The angiogenic function of nucleolin is mediated by vascular endothelial growth factor and nonmuscle myosin. Blood. 2006; 107: 3564\u20133571.","DOI":"10.1182\/blood-2005-07-2961"},{"key":"i1552-5783-59-8-3294-b58","doi-asserted-by":"crossref","unstructured":"Christian S, Pilch J, Akerman ME, Porkka K, Laakkonen P, Ruoslahti E. Nucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vessels. J Cell Biol. 2003; 163: 871\u2013878.","DOI":"10.1083\/jcb.200304132"},{"key":"i1552-5783-59-8-3294-b59","doi-asserted-by":"crossref","unstructured":"Fogal V, Sugahara KN, Ruoslahti E, Christian S. Cell surface nucleolin antagonist causes endothelial cell apoptosis and normalization of tumor vasculature. Angiogenesis. 2009; 12: 91\u2013100.","DOI":"10.1007\/s10456-009-9137-5"},{"key":"i1552-5783-59-8-3294-b60","doi-asserted-by":"crossref","unstructured":"Yingchuan F, Chuntao L, Hui C, Jianbin H. Increased expression of TGF-\u00df1 and Smad 4 on oxygen-induced retinopathy in neonatal mice. Adv Exp Med Biol. 2010; 664: 71\u201377.","DOI":"10.1007\/978-1-4419-1399-9_9"},{"key":"i1552-5783-59-8-3294-b61","doi-asserted-by":"crossref","unstructured":"Braunger BM, Leimbeck SV, Schlecht A, Volz C, Jagle H, Tamm ER. Deletion of ocular transforming growth factor \u00df signaling mimics essential characteristics of diabetic retinopathy. Am J Pathol. 2015; 185: 1749\u20131768.","DOI":"10.1016\/j.ajpath.2015.02.007"},{"key":"i1552-5783-59-8-3294-b62","doi-asserted-by":"crossref","unstructured":"Schlecht A, Leimbeck SV, Jagle H, Feuchtinger A, Tamm ER, Braunger BM. Deletion of endothelial transforming growth factor-\u00df signaling leads to choroidal neovascularization. Am J Pathol. 2017; 187: 2570\u20132589.","DOI":"10.1016\/j.ajpath.2017.06.018"},{"key":"i1552-5783-59-8-3294-b63","doi-asserted-by":"crossref","unstructured":"Li J, Bowens N, Cheng L, et al. Myocardin-like protein 2 regulates TGF\u00df signaling in embryonic stem cells and the developing vasculature. Development. 2012; 139: 3531\u20133542.","DOI":"10.1242\/dev.082222"},{"key":"i1552-5783-59-8-3294-b64","doi-asserted-by":"crossref","unstructured":"Trembley MA, Velasquez LS, de Mesy Bentley KL, Small EM. Myocardin-related transcription factors control the motility of epicardium-derived cells and the maturation of coronary vessels. Development. 2015; 142: 21\u201330.","DOI":"10.1242\/dev.116418"},{"key":"i1552-5783-59-8-3294-b65","doi-asserted-by":"crossref","unstructured":"Menendez MT, Ong EC, Shepherd BT, et al. BRG1 (Brahma-Related Gene 1) promotes endothelial Mrtf transcription to establish embryonic capillary integrity. Arterioscler Thromb Vasc Biol. 2017; 37: 1674\u20131682.","DOI":"10.1161\/ATVBAHA.117.309785"},{"key":"i1552-5783-59-8-3294-b66","doi-asserted-by":"crossref","unstructured":"Crider BJ, Risinger GM Jr, Haaksma CJ, Howard EW, Tomasek JJ. Myocardin-related transcription factors A and B are key regulators of TGF-\u00df1-induced fibroblast to myofibroblast differentiation. J Invest Dermatol. 2011; 131: 2378\u20132385.","DOI":"10.1038\/jid.2011.219"},{"key":"i1552-5783-59-8-3294-b67","doi-asserted-by":"crossref","unstructured":"Gasparics A, Sebe A. MRTFs- master regulators of EMT. Dev Dyn. 2017; 247: 396\u2013404.","DOI":"10.1002\/dvdy.24544"},{"key":"i1552-5783-59-8-3294-b68","doi-asserted-by":"crossref","unstructured":"Dejana E, Hirschi KK, Simons M. The molecular basis of endothelial cell plasticity. Nat Commun. 2017; 8: 14361.","DOI":"10.1038\/ncomms14361"},{"key":"i1552-5783-59-8-3294-b69","doi-asserted-by":"crossref","unstructured":"Schwartz MA, Vestweber D, Simons M. A unifying concept in vascular health and disease. Science. 2018; 360: 270\u2013271.","DOI":"10.1126\/science.aat3470"},{"key":"i1552-5783-59-8-3294-b70","doi-asserted-by":"crossref","unstructured":"Zhan Y, Guo J, Yang W, et al. MNK1\/2 inhibition limits oncogenicity and metastasis of KIT-mutant melanoma. J Clin Invest. 2017; 127: 4179\u20134192.","DOI":"10.1172\/JCI91258"},{"key":"i1552-5783-59-8-3294-b71","doi-asserted-by":"crossref","unstructured":"Liu Y, Sun L, Su X, Guo S. Inhibition of eukaryotic initiation factor 4E phosphorylation by cercosporamide selectively suppresses angiogenesis, growth and survival of human hepatocellular carcinoma. Biomed Pharmacother. 2016; 84: 237\u2013243.","DOI":"10.1016\/j.biopha.2016.09.038"},{"key":"i1552-5783-59-8-3294-b72","doi-asserted-by":"crossref","unstructured":"Dennis MD, Kimball SR, Fort PE, Jefferson LS. Regulated in development and DNA damage 1 is necessary for hyperglycemia-induced vascular endothelial growth factor expression in the retina of diabetic rodents. J Biol Chem. 2015; 290: 3865\u20133874.","DOI":"10.1074\/jbc.M114.623058"},{"key":"i1552-5783-59-8-3294-b73","doi-asserted-by":"crossref","unstructured":"Miller WP, Mihailescu ML, Yang C, et al. The translational repressor 4E-BP1 contributes to diabetes-induced visual dysfunction. Invest Ophthalmol Vis Sci. 2016; 57: 1327\u20131337.","DOI":"10.1167\/iovs.15-18719"},{"key":"i1552-5783-59-8-3294-b74","doi-asserted-by":"crossref","unstructured":"Tokunaga CC, Mitton KP, Dailey W, et al. Effects of anti-VEGF treatment on the recovery of the developing retina following oxygen-induced retinopathy. Invest Ophthalmol Vis Sci. 2014; 55: 1884\u20131892.","DOI":"10.1167\/iovs.13-13397"}],"container-title":["Investigative Opthalmology & Visual Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/iovs.arvojournals.org\/article.aspx?articleid=2687325","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:30:54Z","timestamp":1791927054000},"score":1,"resource":{"primary":{"URL":"http:\/\/iovs.arvojournals.org\/article.aspx?doi=10.1167\/iovs.18-23831"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,5]]},"references-count":74,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,7,2]]}},"URL":"https:\/\/doi.org\/10.1167\/iovs.18-23831","relation":{},"ISSN":["1552-5783"],"issn-type":[{"value":"1552-5783","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7,5]]}}}